Loading clinical trials...
Loading clinical trials...
Evaluation of the Portico™ NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis
Conditions
Interventions
Portico™ NG (Navitor) Valve and FlexNav™ Delivery System
Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System
Locations
28
United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Los Robles Regional Medical Center
Thousand Oaks, California, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Advocate Christ Medical Center
Oak Lawn, Illinois, United States
St. Vincent Hospital
Indianapolis, Indiana, United States
Via Christi Regional Medical Center
Wichita, Kansas, United States
Start Date
September 17, 2019
Primary Completion Date
January 12, 2023
Completion Date
December 1, 2027
Last Updated
July 31, 2025
Lead Sponsor
Abbott Medical Devices
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions